RenovoRx, Inc. RNXT
1.66
(0.02)
(1.19%)
as of 25 Sep
- Market cap
- $75.8M
- P/E
- 0.0×
Follow RNXT
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — | — | — |
P/S ratio |
26.43 | 0.00 | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | — | — | — | — | — | — |
P/Operating CF |
(9.83) | (11.82) | — | — | — | — | — | — |
P/B ratio |
5.47 | 6.42 | — | — | — | — | — | — |
Price to Tangible BV |
5.47 | 6.42 | — | — | — | — | — | — |
EV/Sales |
24.45 | 0.00 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
(2.50) | (2.89) | — | — | — | — | — | — |
EV/FCF |
(2.50) | (2.88) | — | — | — | — | — | — |
Quick Ratio |
3.65 | 3.77 | 1.00 | 5.84 | 16.20 | 0.44 | 2.64 | — |
Current Ratio |
4.02 | 4.10 | 1.25 | 6.59 | 17.36 | 0.47 | 2.81 | — |
Net Debt/EBITDA |
0.56 | 0.65 | 0.10 | 0.65 | 3.06 | (0.32) | (2.64) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 139.66% | 545.86% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.18) | (1.13) | — |
Asset Turnover |
0.14 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.98 | 1.04 | 1.00 | 0.89 | 0.94 | 0.93 | 0.87 | — |
Capex/Depreciation |
(1.00) | 0.00 | — | 0.00 | (0.02) | 0.00 | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (225.62%) | (1,192.69%) | (646.98%) | (91.94%) | (1,825.11%) | 29.69% | 30.01% | — | |
| (137.77%) | (183.93%) | (234.38%) | (83.98%) | (69.49%) | (181.55%) | (338.24%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (2,257.56%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(187.92%) | (148.61%) | (3,516.15%) | (160.46%) | (41.20%) | 173.74% | (262.77%) | — |
Average Days of Receivables |
45.18 | 365.00 | — | — | — | — | — | — |
Research and Development Expense of Revenue |
558.24% | 14,011.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
626.63% | 11,600.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
112.82% | 2,730.23% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Graham Net Nets |
0.18 | 0.15 | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
(38.10%) | (30.23%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(36.98%) | (31.86%) | — | — | — | — | — | — |
Revenue per Share |
0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.31) | (0.41) | (1.00) | (0.97) | (1.13) | (1.59) | (1.54) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(0.31) | (0.41) | (1.00) | (0.97) | (1.14) | (1.59) | (1.54) | — |
Cash per Share |
0.20 | 0.32 | 0.11 | 0.71 | 2.91 | 0.81 | 0.98 | — |
Shareholders Equity per Share |
0.15 | 0.20 | (0.29) | 0.68 | 2.94 | (6.62) | (5.02) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.15 | 0.20 | (0.29) | 0.68 | 2.94 | (6.62) | (5.02) | — |
Free Cash Flow |
(10.97) | (9.14) | (10.26) | (8.81) | (5.93) | (3.53) | (3.35) | — |
Working Capital |
5.93 | 5.92 | 0.29 | 6.16 | 15.34 | (2.19) | 1.46 | — |
Capital Expenditures |
0.00 | (0.01) | — | — | (0.01) | — | — | — |
Net Current Asset Value |
5.22 | 4.19 | (3.00) | 6.16 | 15.34 | (14.66) | (10.93) | — |
EV/EBIT |
0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.00 | 0.28 | — | — | 0.00 | — | — | — |
Net Profit Margin |
(994.48%) | (20,497.67%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.17 | 0.00 | — | 0.00 | 117.67 | 0.00 | — | — |
Cash ROIC |
(88.26%) | (78.55%) | 561.47% | (69.91%) | (19.39%) | 34.63% | (93.34%) | — |
Accounts Receivable Turnover |
12.34 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
0.47 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.00 | — |
Inventory Turnover |
0.00 | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
891.85 | 0.00 | 0.00 | 32,485.00 | 21,291.67 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
210.96 | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.09 | — | — | — | — | — | — | — |
Average Payables |
0.69 | 0.57 | 0.55 | 0.53 | 0.34 | 0.35 | 0.35 | — |
Average Assets |
8.11 | 4.79 | 4.37 | 11.78 | 9.10 | 2.09 | 1.14 | — |
Average Common Equity |
4.95 | 0.74 | 1.58 | 10.76 | 0.35 | (12.79) | (12.79) | — |
Columns are period end dates